Hepatic cytokine response can be modulated using the Kupffer cell blocker gadolinium chloride in obstructive jaundice

C Jones1, S A Badger, M Hoper

  • 1Department of Surgery, Institute of Clinical Sciences, Queens University Belfast, United Kingdom.

Insights

Gadolinium chloride (GdCl3) depletion of Kupffer cells in jaundiced rats reduced liver inflammation and enzyme abnormalities. This highlights Kupffer cells

Area of Science:

  • Hepatology
  • Immunology
  • Sepsis Research

Background:

  • Kupffer cells mediate inflammatory responses in sepsis.
  • Gadolinium chloride (GdCl3) depletes Kupffer cells.
  • Obstructive jaundice exacerbates inflammatory responses.

Purpose of the Study:

  • To investigate GdCl3-induced Kupffer cell depletion effects on hepatic inflammation during portal endotoxemia in jaundiced rats.
  • To assess the role of Kupffer cells in exaggerated inflammatory responses in obstructive jaundice.

Main Methods:

  • Wistar rats underwent bile duct ligation (BDL) followed by GdCl3 or saline administration.
  • Isolated hepatic perfusion was performed 24 hours post-treatment.
  • Cytokine levels (TNFα, IL-6) and liver enzymes (bilirubin, ALP, AST) were analyzed.
  • Kupffer cell numbers were quantified using ED1 immunohistochemistry.

Main Results:

  • GdCl3 treatment significantly reduced Kupffer cell counts.
  • Reduced Kupffer cells correlated with significantly lower hepatic TNFα and IL-6 production.
  • GdCl3 attenuated liver enzyme abnormalities (bilirubin, ALP, AST) in jaundiced rats.

Conclusions:

  • Kupffer cell depletion via GdCl3 mitigates hepatic inflammatory cytokine production in response to portal endotoxemia.
  • Hepatic Kupffer cells are critical in driving exaggerated inflammatory responses during obstructive jaundice.
Abstract

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...